ThinkEquity and Roth Capital Partners to acquire a stake in Ampio Pharmaceuticals for $50m.

Synopsis

ThinkEquity, a boutique investment bank, and Roth Capital Partners, a small privately held investment banking company, agreed to acquire a stake in Ampio Pharmaceuticals, a development-stage biopharmaceutical company, for $50m.

Principals

target

Ampio Pharmaceuticals

bidder

Roth Capital Partners

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Market Context

Sort

Seller Team (2)

michael macaluso

Founder and CEO at AMPIO PHARMACEUTICALS INC

Manager

target

Deal

£ 42 M

Total Value

leah brownlee

Of Counsel at Squire Patton Boggs

Lawyer

target

Deal

£ 42 M

Total Value

Bidder Team (1)

byron roth

Chairman and CEO at ROTH CAPITAL PARTNERS LLC

Manager

bidder

Deals

£ 2.11 B

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy